| Long-term trends in antidiabetes drug usage in the US: real-world evidence in patients newly diagnosed with type 2 diabetes O Montvida, J Shaw, JJ Atherton, F Stringer, SK Paul Diabetes care 41 (1), 69-78, 2018 | 270 | 2018 |
| The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study SK Paul, DL Bhatt, O Montvida European Heart Journal 42 (18), 1728-1738, 2021 | 61 | 2021 |
| Weight gain in insulin‐treated patients by body mass index category at treatment initiation: n ew evidence from real‐world data in patients with type 2 diabetes SK Paul, JE Shaw, O Montvida, K Klein Diabetes, Obesity and Metabolism 18 (12), 1244-1252, 2016 | 38 | 2016 |
| Association of cardiometabolic multimorbidity and depression with cardiovascular events in early-onset adult type 2 diabetes: a multiethnic study in the US JE Dibato, O Montvida, F Zaccardi, JA Sargeant, MJ Davies, K Khunti, ... Diabetes care 44 (1), 231-239, 2021 | 29 | 2021 |
| Addition of or switch to insulin therapy in people treated with glucagon‐like peptide‐1 receptor agonists: a real‐world study in 66 583 patients O Montvida, K Klein, S Kumar, K Khunti, SK Paul Diabetes, Obesity and Metabolism 19 (1), 108-117, 2017 | 28 | 2017 |
| Data mining approach to identify disease cohorts from primary care electronic medical records: a case of diabetes mellitus ES Owusu Adjah, O Montvida, J Agbeve, SK Paul The Open Bioinformatics Journal 10 (1), 2017 | 26 | 2017 |
| Temporal trend in young-onset type 2 diabetes—macrovascular and mortality risk: study of UK primary care electronic medical records DN Koye, J Ling, J Dibato, K Khunti, O Montvida, SK Paul Diabetes Care 43 (9), 2208-2216, 2020 | 25 | 2020 |
| Effectiveness of biologic and non-biologic antirheumatic drugs on anaemia markers in 153,788 patients with rheumatoid arthritis: new evidence from real-world data SK Paul, O Montvida, JH Best, S Gale, A Pethoe-Schramm, K Sarsour Seminars in Arthritis and Rheumatism 47 (4), 478-484, 2018 | 22 | 2018 |
| Data mining approach to estimate the duration of drug therapy from longitudinal electronic medical records O Montvida, O Arandjelović, E Reiner, SK Paul The Open Bioinformatics Journal 10 (1), 2017 | 18 | 2017 |
| Long‐term sustainability of glycaemic achievements with second‐line antidiabetic therapies in patients with type 2 diabetes: A real‐world study O Montvida, JE Shaw, L Blonde, SK Paul Diabetes, Obesity and Metabolism 20 (7), 1722-1731, 2018 | 17 | 2018 |
| Evaluating the representativeness of US Centricity electronic medical records with reports from the centers for disease control and prevention: comparative study on office … O Montvida, JE Dibato, S Paul JMIR Medical Informatics 8 (6), e17174, 2020 | 16 | 2020 |
| Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real‐world evidence from primary care JZJ Ling, O Montvida, K Khunti, AL Zhang, CC Xue, SK Paul Diabetes, Obesity and Metabolism 23 (7), 1518-1531, 2021 | 14 | 2021 |
| Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti‐hyperglycaemic drugs, when added to metformin: real world evidence in people … O Montvida, JB Green, J Atherton, SK Paul Diabetic medicine 36 (4), 491-498, 2019 | 14 | 2019 |
| Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK J Ling, D Koye, L Buizen, K Khunti, O Montvida, SK Paul Diabetes, Obesity and Metabolism 23 (5), 1150-1161, 2021 | 13 | 2021 |
| Cardiovascular risk factor burden in people with incident type 2 diabetes in the US receiving antidiabetic and cardioprotective therapies O Montvida, X Cai, SK Paul Diabetes Care 42 (4), 644-650, 2019 | 11 | 2019 |
| Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study O Montvida, S Verma, JE Shaw, SK Paul Diabetes, Obesity and Metabolism 22 (12), 2384-2397, 2020 | 9 | 2020 |
| Third-line antidiabetic therapy intensification patterns and glycaemic control in patients with type 2 diabetes in the USA: a real-world study DN Koye, O Montvida, SK Paul Drugs 80, 477-487, 2020 | 8 | 2020 |
| A choice of bilevel linear programming solving parameters: factoraggregation approach P Orlovs, O Montvida, S Asmuss EUSFLAT-13, Atlantis Press, 2013 | 6 | 2013 |
| Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young-and usual-onset type 2 diabetes from the USA and the UK J Dibato, O Montvida, J Ling, D Koye, WH Polonsky, SK Paul Diabetologia 65 (12), 2066-2077, 2022 | 5 | 2022 |
| Young adult depression, antidepressant prescriptions, and therapy intensification in people with incident depression in the United States J Dibato, O Montvida, WH Polonsky, KL Chin, SK Paul The Primary Care Companion for CNS Disorders 24 (5), 42658, 2022 | 5 | 2022 |
